Haemonetics (HAE) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.87 +0.12%
Revenue Growth %: +2.3%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +2.3%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.83, $0.15 better than the analyst estimate of $0.68. Revenue for the quarter came in at $297.48 million versus the consensus estimate of $270.46 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- Qualcomm expects $40bn in non-handset revenue by fiscal 2029
- H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
